Sweet Syndrome Following SARS-CoV2 Vaccination
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-y...
Main Authors: | Maria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, Francesca Montefusco, Stefano Senatore, Daniela Massi, Emiliano Antiga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/11/1212 |
Similar Items
-
Periorbital necrotizing sweet syndrome: A report of two cases mimicking necrotizing soft tissue infections
by: Hursuong Vongsachang, et al.
Published: (2024-06-01) -
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy
by: Carlo Alberto Maronese, et al.
Published: (2024-01-01) -
Um caso típico de Síndrome de Sweet
by: Maria Lúcia Ramos, et al.
Published: (2013-05-01) -
Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary center
by: Florian Anzengruber, et al.
Published: (2021-01-01) -
Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound
by: Carlo Pipitò, et al.
Published: (2024-01-01)